| Current Price | $1.70 | Mkt Cap | $859.8M |
|---|---|---|---|
| Open | $1.80 | P/E Ratio | 0.00 |
| Prev. Close | $1.70 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.69 - $1.80 | Volume | 12,370,767 |
| 52-Wk Range | $1.69 - $8.58 | Avg. Daily Vol. | 7,622,530 |
| Current Price | $1.70 | Mkt Cap | $859.8M |
|---|---|---|---|
| Open | $1.80 | P/E Ratio | 0.00 |
| Prev. Close | $1.70 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.69 - $1.80 | Volume | 12,370,767 |
| 52-Wk Range | $1.69 - $8.58 | Avg. Daily Vol. | 7,622,530 |
The best Bull and Bear pitches based on recency and number of recommendations.
Speculative Pick (2% max allocation would be wise), Health Care Sector: Many companies who went public via SPACs have been gutted as those who rushed in, now rush out just as quickly, but many fail to realize that SPACs raised debt-free cash for… More
Stock squeeze will run out of steam and crash
Read the most recent pitches from players about CLOV.
Recs
jisifu
(< 20)
Submitted: 2/22/2022 1:24:15 AM :
Start Price:
$9.77
NASDAQ:CLOV Score:
-76.53
I started writing a few articles on hc and tech changes.
https://clovchronicles.substack.com/
basically, clover has a huge TAM and a differentiable product and business model that has a durable sustainable advantage to their larger competition. The clover assistant is a software that presents useful information to the doctor about a patient and it's a bigger deal that one thinks when it comes to detecting diseases and making sure screening is regular.
it's really an interesting approach where an insurer is taking a proactive approach in preventive precision medicine.
Biggest difference from last year and this year is that they have 20+ patents now to solidify their technological moat. the patents give clover an opportunity to pave way to a new wave of adoption for info tech organizing capabilities by physicians.
lives that are managed by their software are +20% in gross margin over their counterparts who dont use the software. this is promising since the industry is known for relatively low margins between 10-15% with debt burden.
Recs
Margaritarius
(< 20)
Submitted: 1/23/2022 12:06:24 AM :
Start Price:
$2.37
NASDAQ:CLOV Score:
-11.30
Speculative Pick (2% max allocation would be wise), Health Care Sector: Many companies who went public via SPACs have been gutted as those who rushed in, now rush out just as quickly, but many fail to realize that SPACs raised debt-free cash for these companies to accelerate their expansion into positive cash flows or outright profit margin; Clover is one such company; With a total debt to capital ratio of 4.61%, reported last Sept, she's operating at 1/10th the average debt ratio in her industry; Pretty smart move ahead of climbing interest rates if you ask me; CLOV also grew revenue 89% in the 3rd quarter as she expands her AI-enabled Medicare Advantage services into new states steadily stealing market share from the broader industry; Palihapatiya’s pick uses AI to bring providers and patients together; Providers actually recommend plans to patients so that they can get the care they need; Brilliant! It’s also recession proof; I’m likely to pass on a new EV when things get tight, but I’m pretty sure I’ll spring for coverage to get the health care I need to stay alive
Recs
link8822
(82.91)
Submitted: 6/10/2021 1:32:01 AM :
Start Price:
$18.09
NASDAQ:CLOV Score:
+75.56
Stock squeeze will run out of steam and crash
Find the members with the highest scoring picks in CLOV.
TMFBwithbike (42.67) Score: +267.54
The Score Leader is the player with the highest score across all their picks in CLOV.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| link8822 | 82.91 | 6/10/2021 |
|
1Y | $18.09 | -90.60% | -15.04% | +75.56 | 1 Comment | |
| TMFdjagielski | 47.42 | 6/14/2021 |
|
5Y | $14.65 | -88.40% | -15.34% | +73.06 | 0 Comment | |
| TMFjimhalley | < 20 | 3/12/2021 |
|
1Y | $8.80 | -80.68% | -8.67% | +72.01 | 1 Comment | |
| baf72167 | < 20 | 6/21/2021 |
|
5Y | $11.40 | -85.09% | -14.41% | +70.67 | 0 Comment | |
| TotoMMB | 27.68 | 3/21/2022 |
|
3Y | $3.47 | -50.99% | -18.74% | +32.25 | 0 Comment | |
| Under5b | < 20 | 9/28/2022 |
|
5Y | $2.02 | -15.85% | -1.38% | +14.46 | 0 Comment | |
| hepanefc | 70.93 |
|
|
3M | $2.25 | -24.45% | -16.81% | +7.64 | 0 Comment | |
| valari25 | 99.55 | 9/30/2022 |
|
5Y | $1.70 | +0.29% | +0.01% | -0.28 | 0 Comment | |
| v0v0v | 93.35 | 9/29/2022 |
|
1Y | $1.82 | -6.60% | -0.39% | -6.21 | 0 Comment | |
|
Margaritarius | < 20 | 1/24/2022 |
|
5Y | $2.37 | -28.12% | -16.83% | -11.30 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
